Abstract The Cardiometabolic Think Tank was convened on June 20, 2014, in Washington,
DC, as a “call to action” activity focused on defining new patient care models and …

The metabolic syndrome is a constellation of clinical risk factors comprising atherogenic
dyslipidemia (low high-density lipoprotein and high triglycerides levels), elevated blood …

Asiatic acid is a triterpenoid isolated from Centella asiatica. The present study aimed to
investigate whether asiatic acid could lessen the metabolic, cardiovascular complications in …

Background Low‐grade inflammation has been hypothesized to underlie the coronary artery
disease (CAD) risk associated with the metabolic syndrome, but the evidence is not …

Introduction Erectile dysfunction is recognized as an opportunity for preventing
cardiovascular (CV) events, and assessing the impairment of penile vascular flow by …

Patients with diabetes mellitus (DM) are at increased risk of developing lower extremity
peripheral arterial disease (PAD). The effect of DM on restenosis and patency rates in …

Critical limb ischemia represents the advanced stage of peripheral artery disease, a health
problem with increasing prevalence. Critical limb ischemia is associated with significant …

Background—Although the role of inflammation in the pathophysiology of peripheral arterial
disease (PAD) is well established, the contribution of insulin resistance (IR) to PAD is less …

Objectives Atherosclerosis is a multifactorial disease and, thus, its clinical manifestations are
likely to present gender-specific differences with respect to their development, course …

Peripheral arterial disease (PAD) is an important healthcare problem and is an indicator of
widespread atherosclerosis in other vascular territories, such as the cerebral and coronary …